The fourth generation rechargeable INS reduces how frequently a patient needs to recharge their implanted device to only once every six months for one hour. 1 This compares to the current recharging interval of once a month for one hour with the Axonics third generation rechargeable INS. The new INS utilizes the same small 5cc form factor as the Axonics R15 ™ and is paired with the same tined lead and intuitive, easy to use patient remote control. Axonics expects the new INS to receive FDA labeling for 20 years of useful life in the body.